background

INSIGHTS

In this section you will find  some insights from the Life Science industry.

January 10, 2019
Ema: patient records and real world data for clinical studies on hemophilia  
A new step on haemophilia clinical studies arrived from the European Medicines Agency. In fact, the EMA guideline dedicated to clinical studies on haemophilia has been revised, in particular for recombinant products based on factor IX derived from human plasma. 


More

January 10, 2019
Envi committee final opinion on the SPC manufacturing waiver makes genericists happy 
The ENVI Committee’s adoption of the Compromise Amendments on the SPC manufacturing waiver proposed regulation make genericists happy and originator disappointed.
 


More

January 10, 2019
Data is the new oil  
The process of digitization is often referred to as digital transformation, and it is profoundly changing the shape of business today, impacting companies in every industry and consumers around the world.


 


More

January 10, 2019
Door-to-door distribution channel for supplements market 
The direct door-to-door selling channel for supplements seems to grow. This data arrived from the Italian Integrators – AIIPA (New Line Market Research data) and AVEDISCO.


 


More

December 19, 2018
Efpia’s position on the Spc manufacturing waiver issue  
The Efpia position on the Spc manufacturing waiver issue is summarized in a post signed by the Efpia Director General, Nathalie Moll, and published on the Federation website on 25 October. 
 


More


December 19, 2018

Trends and drivers of the sports nutrition industry 
Consumers worldwide are adopting healthy living and fitness trends, especially across developed markets where healthy lifestyles have become the new normal; as a result, this is expanding the consumer base for sports nutrition products.
 


More

December 19, 2018
Lighting reconstruction of clean rooms  
The industrial lighting reconstruction with an energetic purpose is of great importance for the pharmaceutical industry, strongly regulated and presenting the need for a tracked and controlled production.

 


More

December 19, 2018
How to increase turnover at the end of the patent life 
They are called “aspirational strategies”, they deal with the issue of patent expiration and generic competition with the aim of maximizing the potential growth of a compound in the market.

 


More

December 6, 2018
Food supplements: the new electronic notification procedure  
The electronic notification procedure for food supplements became officially effective on Monday 2 July 2018. This procedure covers all “food subject to notification”. All the information could be accessible in the Ministry of Health website. 


More

December 6, 2018
5G revolution, are we ready? 
5G means hyper-connections between an ever-increasing number of connected devices.
The implementation of 5G technologies will allow the definitive affirmation of the Internet of Things. But there are some health risks that must be considered. 
What interests will prevail? 


More

December 6, 2018
Global oral solid dosage pharma formulation market projections  
The global oral solid dosage pharmaceutical formulation market to grow from US$ 493.2 Bn in 2017 to US$ 926.3 Bn by 2027 end. This represents a value CAGR of 6.5% over the forecast period 2017– 2027. Several important factors drive this growth.  


More

November 30, 2018
African pharmaceutical market 
Based on African Pharmaceuticals Market Report of Frost and Sullivan of 2016, the pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020. Goldstein Research analyst forecast the Africa pharmaceuticals market size is set to reach USD 160.7 billion by 2024. 


More

November 20, 2018
Sterile drugs: FDA New Inspection Protocol Project 
The new electronic protocol Nipp of FDA intends to update new steps to modernize the inspections program with a new way of assessing, recording and reporting the data from surveillance and pre-approval inspections for sterile drugs. 


More

November 18, 2018
What about Made in China 2025 
“Made in China 2025” is the government’s ten year plan released in 2015 to update China’s manufacturing power by rapidly developing ten high-tech industries.
The plan proposed a “three step” strategy of transforming China into a leading manufacturing power by the year 2049. 


More

November 18, 2018
EMA launches new corporate website 
This new version will help EMA to further improve its communication with partners and stakeholders, including the European Commission and our networks, and will support the Agency by providing them with evidence-based information on medicines. 


More

November 18, 2018
E-commerce in healthcare market 
China is at the moment the second largest pharmaceutical market in the world. In a country with a rapidly increasing average age and a very low percentage of GDP still being spent on pharmaceutical spending, the opportunities for developing pharma are enormous.


More